Gossamer Bio GOSS Earnings Call Transcripts

NASDAQ GOSS
$11.28 +0.63 (+5.97%)
At close: Nov 10, 2026 · 4:00 PM EST
2 earnings calls on file for Gossamer Bio, from Q1 2020 to Q1 2026. Each transcript opens in a new tab.
Latest earnings call

Gossamer Bio Q1 2026 Earnings Call

May 18, 2026 5,363 words · 23 min read
  • Faheem HasnainChief Executive Officer
  • Bryan GiraudoChief Financial Officer
  • Caryn PetersonChief Regulatory Officer
  • Robert RoscignoChief Development Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Gossamer Bio Earnings Call Transcripts

Calls2
LatestMay 18, 2026
SinceQ1 2020

Fiscal 2026

Fiscal 2020

All 2 Gossamer Bio transcripts Register to get access to Gossamer Bio’s earnings call transcripts.